Synthesis and Antitumor Activity of 5-Bromo-1-mesyluracil (CROSBI ID 107201)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Glavaš-Obrovac, Ljubica ; Karner, Ivan ; Pavlak, Marina ; Radačić, Marko ; Kašnar-Šamprec, Jelena ; Žinić, Biserka
engleski
Synthesis and Antitumor Activity of 5-Bromo-1-mesyluracil
Large scale preparation of 5-bromo-1-mesyluracil (BMsU) 4 has been optimized. BMsU was synthesized by condensation of silylated 5-bromouracil and MsCl in acetonitrile or by the reaction of 5-bromouracil with MsCl in pyridine. The same product was obtained by bromination of 1-mesyluracil. The purpose of this study was to elucidate the effects of BMsU on the biosynthetic activity of tumor cell enzymes involved in DNA, RNA and protein syntheses, and in de novo and salvage pyrimidine and purine syntheses. Investigations were performed in vitro on human cervix carcinoma cells (HeLa). BMsU displayed inhibitory effects on DNA and RNA syntheses in HeLa cells after 24 hours of treatment. De novo biosynthesis of pyrimidine and purine was also affected. Antitumor activity of BMsU is closely associated with its inhibitory activity on the enzymes that play an important role in the metabolism of tumor cells. In vivo antitumor activity of BMsU was also investigated. The model used in investigations was a mouse anaplastic mammary carcinoma transplanted into the thigh of the right leg of CBA mice. Significant reduction in tumor growth time was achieved with BMsU administrated at a dose of 50 mg/kg.
N-1-Sulfonylpyrimidine derivatives; Human cervix carcinoma cell (HeLa); Enzyme activity; Anaplastic mammary carcinoma
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Kemija, Temeljne medicinske znanosti, Biologija